MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 60 filers reported holding MARKER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $0 | – | 700 | +944.8% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 67 | -97.2% | 0.00% | – |
Q1 2021 | $5,000 | -37.5% | 2,415 | -56.2% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 5,518 | +289.7% | 0.00% | – |
Q3 2020 | $2,000 | -75.0% | 1,416 | -62.6% | 0.00% | – |
Q2 2020 | $8,000 | -46.7% | 3,786 | -50.7% | 0.00% | – |
Q1 2020 | $15,000 | -6.2% | 7,677 | +41.4% | 0.00% | – |
Q4 2019 | $16,000 | +166.7% | 5,431 | +304.1% | 0.00% | – |
Q3 2019 | $6,000 | -90.0% | 1,344 | -82.3% | 0.00% | – |
Q2 2019 | $60,000 | -80.5% | 7,591 | -83.7% | 0.00% | – |
Q1 2019 | $307,000 | – | 46,541 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |